Adoptive Immunotherapy via Donor Lymphocyte Infusions Following Allogeneic Haematopoietic Stem Cell Transplantation for Myelofibrosis: A Real World, Retrospective Multi-Centre Study.

Investigators performed a retrospective ‘real world’ analysis of a multicentre cohort of myelofibrosis allogeneic hematopoietic cell transplantation patients from 8 European transplant centers who received donor lymphocyte infusions between 2005-2022.